SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ... Nature 599 (7883), 114-119, 2021 | 1473* | 2021 |
Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations A Rambaut, N Loman, O Pybus, W Barclay, J Barrett, A Carabelli, ... virological.org, 1-5, 2020 | 955* | 2020 |
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets TP Peacock, DH Goldhill, J Zhou, L Baillon, R Frise, OC Swann, ... Nature Microbiology 6 (7), 899-909, 2021 | 730* | 2021 |
SARS-CoV-2 variant biology: immune escape, transmission and fitness AM Carabelli, TP Peacock, LG Thorne, WT Harvey, J Hughes, ... Nature Reviews Microbiology 21 (3), 162-177, 2023 | 642 | 2023 |
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ... Nature medicine, 1-1, 2022 | 628* | 2022 |
The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein TP Peacock, JC Brown, J Zhou, N Thakur, K Sukhova, J Newman, ... bioRxiv, 2022 | 372* | 2022 |
A global perspective on H9N2 avian influenza virus. TP Peacock, J James, JE Sealy, M Iqbal Viruses 11 (620), 2019 | 303* | 2019 |
Affimer proteins are versatile and renewable affinity reagents C Tiede, R Bedford, SJ Heseltine, G Smith, I Wijetunga, R Ross, ... Elife 6, e24903, 2017 | 206 | 2017 |
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination C Davis, N Logan, G Tyson, R Orton, WT Harvey, JS Perkins, G Mollett, ... PLoS Pathogens 17 (12), e1010022, 2021 | 197* | 2021 |
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies MG Cox, TP Peacock, WT Harvey, J Hughes, DW Wright, ... Nature Reviews Microbiology 21 (2), 112-124, 2023 | 166 | 2023 |
SARS-CoV-2 one year on: evidence for ongoing viral adaptation TP Peacock, R Penrice-Randal, JA Hiscox, WS Barclay Journal of General Virology 102 (4), 001584, 2021 | 150 | 2021 |
The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin TP Peacock, CM Sheppard, JC Brown, N Goonawardane, J Zhou, ... bioRxiv, 2021 | 107* | 2021 |
KAP1 regulates endogenous retroviruses in adult human cells and contributes to innate immune control CHC Tie, L Fernandes, L Conde, L Robbez‐Masson, RP Sumner, ... EMBO reports 19 (10), e45000, 2018 | 104 | 2018 |
Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape JC Brown, DH Goldhill, J Zhou, TP Peacock, R Frise, N Goonawardane, ... bioRxiv, 2021 | 101* | 2021 |
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK V Hill, L Du Plessis, TP Peacock, D Aggarwal, R Colquhoun, AM Carabelli, ... Virus Evolution 8 (2), veac080, 2022 | 94 | 2022 |
Evasion of neutralising antibodies by omicron sublineage BA.2.75 DJ Sheward, C Kim, J Fischbach, S Muschiol, RA Ehling, NK Björkström, ... The Lancet Infectious Diseases, 2022 | 83 | 2022 |
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes T Sanderson, R Hisner, I Donovan-Banfield, H Hartman, A Løchen, ... Nature 623 (7987), 594-600, 2023 | 77* | 2023 |
Context-specific emergence and growth of the SARS-CoV-2 Delta variant JT McCrone, V Hill, S Bajaj, RE Pena, BC Lambert, R Inward, S Bhatt, ... Nature 610 (7930), 154-160, 2022 | 77* | 2022 |
ANP32 proteins are essential for influenza virus replication in human cells E Staller, CM Sheppard, PJ Neasham, B Mistry, TP Peacock, DH Goldhill, ... Journal of virology 93 (17), 10.1128/jvi. 00217-19, 2019 | 77 | 2019 |
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies DJ Sheward, C Kim, J Fischbach, K Sato, S Muschiol, RA Ehling, ... The Lancet Infectious Diseases 22 (11), 1538-1540, 2022 | 74 | 2022 |